Patient Centered Results for Uterine Fibroids
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Evan R Myers, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Medical Centers
San Francisco, California, United States
- Uniformed Services University of the Health Sciences
Bethesda, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Inova Health Systems
Falls Church, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2015
- Primary completion
- 30 Apr 2020
- Completion
- 30 Apr 2020
- Last update posted
- 18 Nov 2020
- Registered enrollment
- 3,094
- Registry id
- NCT02260752
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.